Paediatric familial hypercholesterolaemia screening in Europe - public policy background and recommendations.
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209775%3A_____%2F22%3AN0000011" target="_blank" >RIV/00209775:_____/22:N0000011 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/22:00127655
Result on the web
<a href="https://academic.oup.com/eurjpc/article/29/18/2301/6691825?login=false" target="_blank" >https://academic.oup.com/eurjpc/article/29/18/2301/6691825?login=false</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1093/eurjpc/zwac200" target="_blank" >10.1093/eurjpc/zwac200</a>
Alternative languages
Result language
angličtina
Original language name
Paediatric familial hypercholesterolaemia screening in Europe - public policy background and recommendations.
Original language description
Familial hypercholesterolaemia (FH) is under-recognized and under-treated in Europe leading to significantly higher risk for premature heart disease in those affected. As treatment beginning early in life is highly effective in preventing heart disease and cost-effective in these patients, screening for FH is crucial. It has therefore now been recognized by the European Commission Public Health Best Practice Portal as an effective strategy. Model programmes exist in Europe to identify young individuals with FH, which are based on cascade screening of first-degree relatives of affected individuals, universal screening for high cholesterol, opportunistic screening of high-risk individuals, or a combination of the above approaches. Recommendations presented herein to improve identification of FH emphasize that every country should have an FH screening programme. These programmes should be adapted from existing strategies to best fit the individual country's healthcare system, governments should provide financial support for these programmes and related care, and further research to optimize care and implementations should be conducted.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30202 - Endocrinology and metabolism (including diabetes, hormones)
Result continuities
Project
<a href="/en/project/LX22NPO5104" target="_blank" >LX22NPO5104: National Institute for Research of Metabolic and Cardiovascular Diseases</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
European Journal of Preventive Cardiology
ISSN
2047-4873
e-ISSN
2047-4881
Volume of the periodical
29
Issue of the periodical within the volume
18
Country of publishing house
GB - UNITED KINGDOM
Number of pages
11
Pages from-to
2301–2311
UT code for WoS article
000860847200001
EID of the result in the Scopus database
2-s2.0-85140631500